Your browser doesn't support javascript.
loading
S100A1 DNA-based Inotropic Therapy Protects Against Proarrhythmogenic Ryanodine Receptor 2 Dysfunction.
Ritterhoff, Julia; Völkers, Mirko; Seitz, Andreas; Spaich, Kristin; Gao, Erhe; Peppel, Karsten; Pleger, Sven T; Zimmermann, Wolfram H; Friedrich, Oliver; Fink, Rainer H A; Koch, Walter J; Katus, Hugo A; Most, Patrick.
Afiliação
  • Ritterhoff J; Molecular and Translational Cardiology, Department of Internal Medicine III, Heidelberg University Hospital, Heidelberg, Germany. Electronic address: jr54@uw.edu.
  • Völkers M; Molecular and Translational Cardiology, Department of Internal Medicine III, Heidelberg University Hospital, Heidelberg, Germany.
  • Seitz A; Molecular and Translational Cardiology, Department of Internal Medicine III, Heidelberg University Hospital, Heidelberg, Germany.
  • Spaich K; Molecular and Translational Cardiology, Department of Internal Medicine III, Heidelberg University Hospital, Heidelberg, Germany.
  • Gao E; Center for Translational Medicine, Department of Pharmacology, School of Medicine, Temple University, Philadelphia, Pennsylvania, USA.
  • Peppel K; Center for Translational Medicine, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Pleger ST; Molecular and Translational Cardiology, Department of Internal Medicine III, Heidelberg University Hospital, Heidelberg, Germany.
  • Zimmermann WH; Institute of Pharmacology, Heart Research Center Göttingen, Georg-August-University Göttingen, Göttingen, Germany; German Center for Cardiovascular Research (DZHK), partner site Göttingen, Göttingen, Germany.
  • Friedrich O; Institute of Medical Biotechnology, University of Erlangen-Nürnberg, Erlangen, Germany.
  • Fink RHA; Institute of Physiology and Pathophysiology, Medical Biophysics, University of Heidelberg, Heidelberg, Germany.
  • Koch WJ; Center for Translational Medicine, Department of Pharmacology, School of Medicine, Temple University, Philadelphia, Pennsylvania, USA.
  • Katus HA; Molecular and Translational Cardiology, Department of Internal Medicine III, Heidelberg University Hospital, Heidelberg, Germany; German Centre for Cardiovascular Research (DZHK), partner site Heidelberg/Mannheim, Heidelberg, Germany.
  • Most P; Molecular and Translational Cardiology, Department of Internal Medicine III, Heidelberg University Hospital, Heidelberg, Germany; Center for Translational Medicine, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA; German Centre for Cardiovascular Research (DZHK),
Mol Ther ; 23(8): 1320-1330, 2015 Aug.
Article em En | MEDLINE | ID: mdl-26005840

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas S100 / Canal de Liberação de Cálcio do Receptor de Rianodina / Insuficiência Cardíaca Limite: Animals Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas S100 / Canal de Liberação de Cálcio do Receptor de Rianodina / Insuficiência Cardíaca Limite: Animals Idioma: En Ano de publicação: 2015 Tipo de documento: Article